Back stories here.
French pharmaceutical company Sanofi-Aventis temporarily suspended sales of anti-obesity drug Acomplia in Europe, the company said Thursday, after health authorities said the drug's risks outweigh its benefits.Sanofi-Aventis will "immediately" start talks with non-EU countries where the drug is available to have sales suspended there as well, the company said in a statement.
The decision follows a recommendation from the London-based European Medicines Agency, which earlier Thursday said a study had revealed obese or overweight patients taking Acomplia were at approximately double the risk of developing psychiatric disorders than those taking a placebo.
More
Insider says: Just as Insider predicted nearly a year ago.
No comments:
Post a Comment